DocGo (NASDAQ:DCGO) Stock Keeps Buy Rating at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday, Benzinga reports.

Several other equities analysts have also recently weighed in on the company. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $1.00 price objective on shares of DocGo in a report on Tuesday, August 18th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $2.38.

DocGo Stock Performance

Shares of NASDAQ DCGO opened at $0.39 on Wednesday. The stock has a market cap of $38.58 million, a P/E ratio of -0.19 and a beta of 0.94. The firm has a 50 day moving average price of $0.48 and a 200 day moving average price of $0.56. DocGo has a 52-week low of $0.31 and a 52-week high of $1.65.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The firm had revenue of $73.42 million for the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. Analysts predict that DocGo will post -0.22 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Diversify Advisory Services LLC bought a new stake in DocGo during the 2nd quarter valued at $53,000. Isthmus Partners LLC raised its holdings in shares of DocGo by 14.0% in the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after acquiring an additional 124,211 shares in the last quarter. Empowered Funds LLC bought a new stake in DocGo in the 2nd quarter worth approximately $79,000. Ieq Capital LLC bought a new stake in shares of DocGo in the 2nd quarter worth approximately $126,000. Finally, Marquette Asset Management LLC bought a new position in DocGo in the second quarter worth $175,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.